GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » EV-to-EBITDA

DocMorris AG (XSWX:DOCM) EV-to-EBITDA : -20.39 (As of May. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DocMorris AG's enterprise value is CHF1,143.7 Mil. DocMorris AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-56.1 Mil. Therefore, DocMorris AG's EV-to-EBITDA for today is -20.39.

The historical rank and industry rank for DocMorris AG's EV-to-EBITDA or its related term are showing as below:

XSWX:DOCM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -664.05   Med: -27.85   Max: -3.08
Current: -20.39

During the past 13 years, the highest EV-to-EBITDA of DocMorris AG was -3.08. The lowest was -664.05. And the median was -27.85.

XSWX:DOCM's EV-to-EBITDA is ranked worse than
100% of 460 companies
in the Healthcare Providers & Services industry
Industry Median: 13.06 vs XSWX:DOCM: -20.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-06), DocMorris AG's stock price is CHF81.95. DocMorris AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF7.050. Therefore, DocMorris AG's PE Ratio for today is 11.62.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


DocMorris AG EV-to-EBITDA Historical Data

The historical data trend for DocMorris AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG EV-to-EBITDA Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -83.28 -37.04 -16.69 -5.96 -18.67

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.69 - -5.96 - -18.67

Competitive Comparison of DocMorris AG's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, DocMorris AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DocMorris AG's EV-to-EBITDA falls into.



DocMorris AG EV-to-EBITDA Calculation

DocMorris AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1143.698/-56.082
=-20.39

DocMorris AG's current Enterprise Value is CHF1,143.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-56.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocMorris AG  (XSWX:DOCM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

DocMorris AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=81.95/7.050
=11.62

DocMorris AG's share price for today is CHF81.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF7.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


DocMorris AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of DocMorris AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines